Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. The company was founded in 2003 and is headquartered in Wuhan, the People’s Republic of China.

Sector

Healthcare

Industry

Medical - Care Facilities

CEO

Huang, Shiang

Employees

3,162

Website

www.kindstar.com.cn

IPO Date

2021-07-16

Headquarters

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Wuhan, Hubei Province China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.